UPCOMING EVENT The State of Biosimilars: What to Watch
Virtual
Tuesday, July 18 at 1 p.m. ET
Register Now
Now that biosimilar versions of Humira are starting to arrive, what happens next?
Pharmalot's Ed Silverman, together with featured speakers, will explore if this will finally prove the case that biosimilars can deliver on big health care savings.
Register now, and be ready to dive in and discuss what to watch in the months ahead.
No comments